As mentioned, a secondary analysis of an RCT assessing the cardiometabolic effects of exenatide in 40 people with schizophrenia 140 also looked at measures of cognition and psychosocial functioning (that is, Brief Assessment of Cognition in Schizophrenia, ReyOsterreith Complex Figure Test, Short-Form Health Survey, Personal and Social Performance Scale, Positive and Negative Syndrome Scale), but found no effect for this GLP-1RA compared with placebo over 3 months 133
MAPK/ERK pathway drives cell proliferation and differentiation
The number of Alzheimers disease (AD) patients in the U.S
However, there is still lack of effective clinical treatment for hyperuricaemia
4 Discussion As shown in Figure 1, the mitochondria-targeted antioxidant SkQ1 and the redox agent methylene blue, which inhibits ROS production by complex I of the mitochondrial electron transport chain, prevent ferroptosis induced by ferric ammonium citrate in combination with the glutathione biosynthesis inhibitor BSO
Factors such as body weight, metabolism and desired results should all be taken into consideration when determining an appropriate dosage